COMPASS Pathways plc (CMPS) prices 24M ADS at $5.796

Go back to COMPASS Pathways plc (CMPS) prices 24M ADS at $5.796

Compass Pathways Announces Pricing of Underwritten Offering

January 10, 2025 7:01 AM UTC

LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (ADSs) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to 11,044,720 ADSs. Each ADS and pre-funded warrant shall be accompanied by a warrant (ADS Warrant) to purchase one ADS, which has an exercise price of $5.796 per ADS, representing a 40% premium to the last sale price and will be exercisable following a specified data milestone.... More